Skip to main content

Peer Review reports

From: Association between tocilizumab and emerging multidrug-resistant organisms in critically ill patients with COVID-19: A multicenter, retrospective cohort study

Original Submission
27 Apr 2021 Submitted Original manuscript
16 Jun 2021 Reviewed Reviewer Report
6 Jul 2021 Reviewed Reviewer Report
21 Jul 2021 Reviewed Reviewer Report - Christian Pallares
16 Aug 2021 Author responded Author comments - Ohoud Aljuhani
Resubmission - Version 2
16 Aug 2021 Submitted Manuscript version 2
19 Aug 2021 Author responded Author comments - Ohoud Aljuhani
Resubmission - Version 3
19 Aug 2021 Submitted Manuscript version 3
20 Aug 2021 Author responded Author comments - Ohoud Aljuhani
Resubmission - Version 4
20 Aug 2021 Submitted Manuscript version 4
4 Sep 2021 Reviewed Reviewer Report
30 Sep 2021 Author responded Author comments - Ohoud Aljuhani
Resubmission - Version 5
30 Sep 2021 Submitted Manuscript version 5
6 Oct 2021 Author responded Author comments - Ohoud Aljuhani
Resubmission - Version 6
6 Oct 2021 Submitted Manuscript version 6
8 Oct 2021 Author responded Author comments - Ohoud Aljuhani
Resubmission - Version 7
8 Oct 2021 Submitted Manuscript version 7
Publishing
22 Oct 2021 Editorially accepted
1 Nov 2021 Article published 10.1186/s12879-021-06813-1

You can find further information about peer review here.

Back to article page